The chemistry of the non-metals / by 241801 Powell, P.

Principles of organometallic chemistry/ by 241801 Powell, P.

HE-I AND HE-II PHOTOELECTRON SPECTROSCOPIC STUDIES OF THE BONDING IN COBALT, RHODIUM, AND IRIDIUM CYCLOPENTADIENYL DIENE COMPLEXES by Green, J, Powell, P, Vantilborg, J

HE-I AND HE-II PHOTOELECTRON-SPECTRA OF OPEN-CHAIN PENTADIENYL COMPLEXES OF MANGANESE AND RHENIUM by Green, J, Pazsandoval, M, Powell, P

HE(I) PHOTOELECTRON-SPECTRA OF TRICARBONYL-IRON AND TRICARBONYL-RUTHENIUM COMPLEXES OF CYCLIC DIENES, AND OF TRICARBONYLCYCLOHEPTATRIENE- IRON AND TRICARBONYLCYCLO-OCTATETRAENE-IRO... by Green, J, Powell, P, Vantilborg, J

The differential contribution of B and T lymphocytes to susceptibility to Marek's disease in RPL line-7 chickens. by Powell, P, Irving, N, Prynne, A, Rennie, M

Mechanism of inactivation of NF-kappa B by a viral homologue of I kappa b alpha. Signal-induced release of i kappa b alpha results in binding of the viral homologue to NF-kappa B. by Tait, S, Reid, E, Greaves, D, Wileman, T, Powell, P

PHOTOELECTRON-SPECTRA OF METALLOCENES by Cauletti, C, Green, J, Kelly, M, Powell, P, Vantilborg, J, Robbins, J, Smart, J

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT st... by Donovan, J, Peters, T, Noble, S, Powell, P, Gillatt, D, Oliver, SE, Lane, J, Neal, D, Hamdy, F

The value of repeat serum PSA measurements in the detection of prostate cancer - Experience from the feasibility phase of the UK protect study by Hamdy, F, Dedman, D, Lane, A, Oliver, S, Powell, P, Leung, H, Gillatt, D, Neal, D, Donovan, J

Development of a complex intervention improved randomization and informed consent in a randomized controlled trial. by Donovan, J, Lane, J, Peters, T, Brindle, L, Salter, E, Gillatt, D, Powell, P, Bollina, P, Neal, D, Hamdy, F

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer. by Moore, A, Dimitropoulou, P, Lane, A, Powell, P, Greenberg, D, Brown, C, Donovan, J, Hamdy, F, Martin, R, Neal, D

Insights into the pathophysiology of catch-up compared with non-catch-up growth in children born small for gestational age: an integrated analysis of metabolic and transcriptomic d... by Stevens, A, Bonshek, C, Whatmore, A, Butcher, I, Hanson, D, De Leonibus, C, Shaikh, G, Brown, M, O'Shea, E, Victor, S, Powell, P, Settle, P, Padmakumar, B, Tan, A, Odeka, E, Cooper, C, Birch, J, Shenoy, A, Westwood, M, Patel, L, Dunn, B, Clayton, P

10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer by Hamdy, F, Donovan, J, Lane, J, Mason, M, Metcalfe, C, Holding, P, Davis, M, Peters, T, Turner, E, Martin, R, Oxley, J, Robinson, M, Staffurth, J, Walsh, E, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Kockelbergh, R, Kynaston, H, Paul, A, Powell, P, Prescott, S, Rosario, D, Rowe, E, Neal, D

Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer by Hamdy, FC, Donovan, JL, Lane, JA, Metcalfe, C, Davis, M, Turner, EL, Martin, RM, Young, GJ, Walsh, EI, Bryant, RJ, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Rosario, DJ, Rowe, E, Mason, M, Catto, JWF, Peters, TJ, Oxley, J, Williams, NJ, Staffurth, J, Neal, DE

Mortality among nen with advanced prostate cancer excluded from the ProtecT Trial by Johnston, T, Shaw, G, Lamb, A, Parashar, D, Greenberg, D, Xiong, T, Edwards, A, Gnanapragasam, V, Holding, P, Herbert, P, Davis, M, Mizielinsk, E, Lane, J, Oxley, J, Robinson, M, Mason, M, Staffurth, J, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Kockelbergh, R, Kynaston, H, Prescott, S, Paul, A, Powell, P, Rosario, D, Rowe, E, Donovan, J, Hamdy, F, Neal, D, ProtecT study group

Patient-reported outcomes 12 years after localized prostate cancer treatment by Donovan, JL, Hamdy, FC, Lane, JA, Young, GJ, Metcalfe, C, Walsh, EI, Davis, M, Steuart-Feilding, T, Blazeby, JM, Avery, KNL, Martin, RM, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Rosario, DJ, Rowe, E, Mason, M, Catto, JWF, Peters, TJ, Wade, J, Turner, EL, Williams, NJ, Oxley, J, Staffurth, J, Bryant, RJ, Neal, DE

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT by Hamdy, FC, Donovan, JL, Lane, JA, Mason, M, Metcalfe, C, Peter Holding, Wade, J, Noble, S, Garfield, K, Young, G, Davis, M, Peters, TJ, Turner, EL, Martin, RM, Oxley, J, Robinson, M, Staffurth, J, Walsh, E, Blazeby, J, Bryant, R, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Prescott, S, Rosario, D, Rowe, E, Neal, D

Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer by Donovan, J, Hamdy, F, Lane, J, Mason, M, Metcalfe, C, Walsh, E, Blazeby, J, Peters, T, Holding, P, Bonnington, S, Lennon, T, Bradshaw, L, Cooper, D, Herbert, P, Howson, J, Jones, A, Lyons, N, Salter, E, Thompson, P, Tidball, S, Blaikie, J, Gray, C, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Kockelbergh, R, Kynaston, H, Paul, A, Powell, P, Prescott, S, Rosario, D, Rowe, E, Davis, M, Turner, E, Martin, R, Neal, D, ProtecT Study Group